A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade gastroenteropanncreatic or lung neuroendocrine carcinoma.

已取消 10 由行止发布于 2024/9/3 22:14:02

DOI:10.1200/jco.2020.38.4_suppl.tps635
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1200/jco.2020.38.4_suppl.tps635

American Society of Clinical Oncology (ASCO)

Abstract：TPS635Background: Combination chemotherapy (CTx) is the mainstay of treatment for patients with advanced high-grade gastroenteropancreatic neuroendocrine carcinoma (GEPNECs) and large cell n

应助信息

2024-09-03

Book学术机器人

2024/9/3 22:14:02 未找到该文献，机器人已退出，请等待人工下载

2024/9/3 22:14:02 Book学术AI机器人收到请求，开始寻找文献

2024/9/3 22:14:02 已向机器人发送请求

2024-09-03

行止发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Society of Clinical Oncology (ASCO)A pilot study of adjuvant chemotherapy with cisplatin and irinotecan for high-grade pulmonary neuroendocrine carcinona (large cell neuroendocrine carcinoma and small cell lung cancer).